For­mer Zymeworks CEO Ali Tehrani lands at Cana­di­an VC Am­pli­tude, look­ing to guide new com­pa­ny builders 'punch­ing above their weight'

Long­time Zymeworks CEO Ali Tehrani, who left the com­pa­ny in Jan­u­ary, has found his next gig — and it’s one where he hopes he can serve as a men­tor to younger ver­sions of him­self.

Tehrani joined Am­pli­tude Ven­ture Cap­i­tal as a ven­ture part­ner, the Cana­di­an firm an­nounced last week, aim­ing to con­tin­ue build­ing biotech com­pa­nies from the oth­er side of the ta­ble. Not on­ly is Tehrani ex­cit­ed to get back to work, but he wants to help Cana­da’s biotech space con­tin­ue grow­ing, a big part of Am­pli­tude’s mis­sion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER